Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

The number of suspected cases of this neurological condition reported from the region has crossed 101. Why is it happening ...

Mathot et al. assess stability of an adenovirus-based vaccine vector lyophilized and stored long-term. The stability of the vaccine remains within an acceptable limit after five years of storage ...

Recurrent respiratory papillomatosis (RRP) is a disease of the upper airway presenting with exophytic wart-like lesions. These lesions are considered benign with less than a 1–5% chance of malignant ...

Age ranged between 23 and 81 (average 51). Vaccination was the only possible trigger in all cases. Six patients had received adenoviral vector-based vaccines (four received AstraZeneca and two ...